Loading...
Chemring Group PLC
CHG.L•LSE
Industrials
Aerospace & Defense
£562.00
£-10.00(-1.75%)
Chemring Group PLC (CHG.L) Financial Performance & Statements
Review Chemring Group PLC’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
8.00%
↑ 8.00%
Operating Income Growth
27.97%
↑ 27.97%
Net Income Growth
631.48%
↑ 631.48%
Operating Cash Flow Growth
22.91%
↑ 22.91%
Operating Margin
11.38%
↑ 11.38%
Gross Margin
43.77%
↑ 43.77%
Net Profit Margin
7.74%
↑ 7.74%
ROE
11.17%
↑ 11.17%
ROIC
12.36%
↑ 12.36%
Chemring Group PLC (CHG.L) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Chemring Group PLC stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $287.00M | $223.40M | $260.50M | $212.10M |
| Cost of Revenue | $287.00M | $0.00 | $0.00 | $5.80M |
| Gross Profit | $0.00 | $223.40M | $260.50M | $206.30M |
| Gross Profit Ratio | $0.00 | $1.00 | $1.00 | $0.97 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $466.60M | $1.90M | $0.00 | $1.50M |
| Operating Expenses | $233.30M | $205.90M | $227.10M | $177.80M |
| Total Costs & Expenses | -$246.40M | $205.90M | $238.10M | $189.10M |
| Interest Income | $0.00 | $0.00 | $0.00 | $1.00M |
| Interest Expense | $2.50M | $2.30M | $300000.00 | $1.00M |
| Depreciation & Amortization | $13.10M | $11.50M | $11.00M | $11.30M |
| EBITDA | $53.70M | $29.00M | $33.40M | $34.30M |
| EBITDA Ratio | $0.19 | $0.13 | $0.13 | $0.16 |
| Operating Income | $40.60M | $17.50M | $22.40M | $23.00M |
| Operating Income Ratio | $0.14 | $0.08 | $0.09 | $0.11 |
| Other Income/Expenses (Net) | -$2.50M | -$2.30M | -$300000.00 | -$1.00M |
| Income Before Tax | $38.10M | $15.20M | $22.10M | $22.00M |
| Income Before Tax Ratio | $0.13 | $0.07 | $0.08 | $0.10 |
| Income Tax Expense | $7.60M | $3.00M | $3.10M | $3.30M |
| Net Income | $23.10M | $16.40M | -$13.30M | $18.70M |
| Net Income Ratio | $0.08 | $0.07 | -$0.05 | $0.09 |
| EPS | $0.09 | $0.03 | -$0.05 | $0.07 |
| Diluted EPS | $0.08 | $0.04 | -$0.05 | $0.06 |
| Weighted Avg Shares Outstanding | $269.47M | $381.40M | $279.48M | $281.71M |
| Weighted Avg Shares Outstanding (Diluted) | $278.10M | $280.60M | $279.48M | $288.62M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan